hema.to GmbH
Martin Becker is a highly skilled professional in immunology and cytometry, currently serving as a Senior Scientist and Immunology Advisor at hema.to GmbH, where expertise in flow-cytometry and immunology aids in developing AI-based diagnostic solutions for hematopoietic disorders. Previously, Martin Becker worked at Matterhorn Biosciences, focusing on advancing T Cell-based therapies, and held the position of Head of New Technology at AVA LifeScience GmbH, where efforts were directed toward improving cancer diagnostics. Martin Becker's academic background includes a Ph.D. in Molecular Immunology from The University of Freiburg and multiple degrees in Biotechnology and Cell and Molecular Biology, with significant research experience at esteemed institutions like Helmholtz Zentrum München and the Max-Planck Institute of Immunobiology and Epigenetics.